Page last updated: 2024-10-25

ciclopirox and Tinea Versicolor

ciclopirox has been researched along with Tinea Versicolor in 5 studies

Tinea Versicolor: A common chronic, noninflammatory and usually symptomless disorder, characterized by the occurrence of multiple macular patches of all sizes and shapes, and varying in pigmentation from fawn-colored to brown. It is seen most frequently in hot, humid, tropical regions and is mostly caused by MALASSEZIA FURFUR (formerly Pityrosporum orbiculare).

Research Excerpts

ExcerptRelevanceReference
"Two randomized, double-blind, parallel-group studies, each conducted at five medical centers, assessed the efficacy and safety of a new antifungal agent, ciclopirox olamine cream 1%, in patients with tinea versicolor."9.05Treatment of tinea versicolor with a new antifungal agent, ciclopirox olamine cream 1%. ( , 1985)
"Two randomized, double-blind, parallel-group studies, each conducted at five medical centers, assessed the efficacy and safety of a new antifungal agent, ciclopirox olamine cream 1%, in patients with tinea versicolor."5.05Treatment of tinea versicolor with a new antifungal agent, ciclopirox olamine cream 1%. ( , 1985)
"90 patients suffering from pityriasis versicolor used a 0."1.28[Topical application of a 0.1% ciclopiroxolamine solution for the treatment of pityriasis versicolor]. ( Corte, M; Jung, K; Linker, U; Martini, H; Sapp-Boncelet, I; Schulz, H, 1989)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
DylÄ…g, M1
Leniak, E1
Gnat, S1
Szepietowski, JC1
Kozubowski, L1
del Palacio-Hernanz, A1
Guarro-Artigas, J1
Figueras-Salvat, MJ1
Esteban-Moreno, J1
Lopez-Gomez, S1
Corte, M1
Jung, K1
Linker, U1
Martini, H1
Sapp-Boncelet, I1
Schulz, H1
Griffith, ML1
Flowers, FP1
Araujo, OE1

Trials

2 trials available for ciclopirox and Tinea Versicolor

ArticleYear
Changes in fungal ultrastructure after short-course ciclopiroxolamine therapy in pityriasis versicolor.
    Clinical and experimental dermatology, 1990, Volume: 15, Issue:2

    Topics: Antifungal Agents; Ciclopirox; Double-Blind Method; Drug Administration Schedule; Humans; Malassezia

1990
Treatment of tinea versicolor with a new antifungal agent, ciclopirox olamine cream 1%.
    Clinical therapeutics, 1985, Volume: 7, Issue:5

    Topics: Adolescent; Adult; Antifungal Agents; Ciclopirox; Clinical Trials as Topic; Clotrimazole; Double-Bli

1985

Other Studies

3 other studies available for ciclopirox and Tinea Versicolor

ArticleYear
A case of anti- pityriasis versicolor therapy that preserves healthy mycobiome.
    BMC dermatology, 2020, 09-29, Volume: 20, Issue:1

    Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Drug Therapy, Combination; Humans; Malassezi

2020
[Topical application of a 0.1% ciclopiroxolamine solution for the treatment of pityriasis versicolor].
    Mycoses, 1989, Volume: 32, Issue:4

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifungal Agents; Child; Ciclopirox; Female; Huma

1989
Superficial mycoses. Therapeutic agents and clinical applications.
    Postgraduate medicine, 1986, Volume: 79, Issue:1

    Topics: Antifungal Agents; Candidiasis; Ciclopirox; Griseofulvin; Humans; Imidazoles; Phenyl Ethers; Pyridon

1986